Posted Jan. 24, 2014 at 12:33 p.m.

Premium Lock Pain drug from BDSI shows positive trial results, triggers $10M milestone

Published: 2014-01-24 12:33:50
Updated: 2014-01-24 12:33:50

Print this blog post
BDSI BDSI

Chronic pain drug BEMA buprenorphine showed positive top-line phase III clinical trial results, and securing trial data for further analysis has triggered a $10 million milestone to BioDelivery Sciences International....

Read More
Read More

WRAL Tech Wire any time: Twitter, Facebook

Copyright 2014 WRAL Tech Wire. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL Tech Wire and WRAL editors. Read more articles…

Please Log In to add a comment.

Best of TechWire Insider

Techwire Inside Partners

OUR INSIDERS

Vivek Wadhwa
Commentary
Frank Vinluan
Life science
Dr. Mike Walden
Tech economy
Scroll